What Is interesting about that August 16 article of the comments attributed to Woolworths.
The "free range" product range has been added to small selection of 20 Woolworths stores whilst the actual number of stocked Woolworths stores doesn't appear to be much greater than this. So muc, then, for the Woolworths supply contract which was heralded last year as been not only significant but of material value and so therefore quite profitable to CDC.
The reality seems to be that the Woolworths supply contract has actually gone backwards in the last 12 months and is now only a speculative, samples spreading of stores. In other words, how much small sampling of stores then what shareholders have previously been led to believe. If so, then this reinforces your argument about the relative decline in CDC sales and revenue generation which has been progressively evident since July 2016.
If in any doubt about this, perhaps look and compare the monthly revenue averages for CDC referred to at the 2016 AGM, the H17 results and the F17 results. In between all these results, a number of interesting (albeit progressively declining) monthly revenue results can all readily be discerned. Several postings from earlier this week also reinforce this view.
So, exactly when was the Woolworths contract substantially changed? And why weren't shareholders previously informed about this?
AHF Price at posting:
11.5¢ Sentiment: Hold Disclosure: Not Held
